These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
751 related articles for article (PubMed ID: 32257050)
21. Good or not good: Role of miR-18a in cancer biology. Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453 [TBL] [Abstract][Full Text] [Related]
22. Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis. Chen Y; Wu Z; Yi X Sci Rep; 2024 Aug; 14(1):19071. PubMed ID: 39154046 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity. Liu M; Zhao H; Peng S; Wu Y; Liu Y; Sun W; Zen K; Sun X FASEB J; 2024 Mar; 38(5):e23523. PubMed ID: 38457275 [TBL] [Abstract][Full Text] [Related]
24. Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers. Lan A; Ren C; Wang X; Tong G; Yang G BMC Cancer; 2021 Apr; 21(1):423. PubMed ID: 33863293 [TBL] [Abstract][Full Text] [Related]
25. Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma. Guo L; Dou Y; Yang Y; Zhang S; Kang Y; Shen L; Tang L; Zhang Y; Li C; Wang J; Liang T; Li X Comput Struct Biotechnol J; 2021; 19():5722-5734. PubMed ID: 34745457 [TBL] [Abstract][Full Text] [Related]
26. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation. Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349 [TBL] [Abstract][Full Text] [Related]
27. Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer Gonçalves PG; Reis RM; Bidinotto LT Anticancer Res; 2022 Nov; 42(11):5291-5304. PubMed ID: 36288884 [TBL] [Abstract][Full Text] [Related]
28. Pan-Cancer Analysis Revealed Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J J Oncol; 2022; 2022():3477148. PubMed ID: 35069733 [TBL] [Abstract][Full Text] [Related]
29. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues. Zhang J; Lu T; Lu S; Ma S; Han D; Zhang K; Xu C; Liu S; Gan L; Wu X; Yang F; Wen W; Qin W Comput Struct Biotechnol J; 2023; 21():665-676. PubMed ID: 36659929 [TBL] [Abstract][Full Text] [Related]
30. CDK1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Pan-Cancer, Especially in Gastrointestinal Tumors. Shen J; Gong X; Tan S; Zhang Y; Xia R; Xu S; Wang S; Zhou H; Jiang Y; Zhao T; Zhang Y; Tang H; Wang C Curr Med Chem; 2024 Jun; ():. PubMed ID: 38952160 [TBL] [Abstract][Full Text] [Related]
31. Differential Expression of the Hu J; Xu J; Feng X; Li Y; Hua F; Xu G Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699 [TBL] [Abstract][Full Text] [Related]
32. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
33. Pan-cancer analysis of the role of α2C-adrenergic receptor (ADRA2C) in human tumors and validation in glioblastoma multiforme models. Zhang X; Chen H; Wang C; Chen C; Liu L; Nie S; Gao X; Huang N; Chen J J Cancer; 2024; 15(17):5691-5709. PubMed ID: 39308687 [No Abstract] [Full Text] [Related]
34. Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes. Khan R; Pari B; Puszynski K Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790205 [TBL] [Abstract][Full Text] [Related]
35. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3. Ling ZN; Hong LL; Wu J; Ling ZQ Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173 [TBL] [Abstract][Full Text] [Related]
36. Neuritin 1 expression in human normal tissues and its association with various human cancers. Dong H; Luo X; Niu Y; Yu N; Gao R; Wang H; Yang L; Huang J Int J Clin Exp Pathol; 2018; 11(4):1956-1964. PubMed ID: 31938301 [TBL] [Abstract][Full Text] [Related]
37. The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas. Ball MW; Gorin MA; Drake CG; Hammers HJ; Allaf ME Eur Urol Focus; 2017 Dec; 3(6):584-589. PubMed ID: 28753846 [TBL] [Abstract][Full Text] [Related]
38. Role of CD47 in tumor immunity: a potential target for combination therapy. Huang J; Liu F; Li C; Liang X; Li C; Liu Y; Yi Z; Zhang L; Fu S; Zeng Y Sci Rep; 2022 Jun; 12(1):9803. PubMed ID: 35697717 [TBL] [Abstract][Full Text] [Related]
39. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors. Ding Q; Li R; Wang Q; Yu L; Zi F Front Oncol; 2023; 13():1049147. PubMed ID: 38053661 [TBL] [Abstract][Full Text] [Related]
40. A pan-cancer analysis of the role of Ding G; Ma T; Zhang K; Chen G; Shen J; Zhang S; Li K; Zhao C; Wang F; Sun J; Wang J Biotechnol Genet Eng Rev; 2024 Nov; 40(3):1456-1471. PubMed ID: 36971139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]